Current report 40/2021 – Admission and introduction of ordinary D-series bearer shares of the Company to stock exchange trading

Date prepared: 09/16/2021                                                                                                                               

Abbreviated name of the issuer: CELON PHARMA S.A.

Subject: Admission and introduction of ordinary D-series bearer shares of the Company to stock exchange trading

Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering – current and periodical information

Content of the report:                                                                                                                                

The Management Board of Celon Pharma S.A. (the “Company”) hereby announces that on 15 September 2021 the Management Board of the Warsaw Stock Exchange (“GPW”) has adopted a resolution concerning the admission and introduction of the Company’s ordinary D-series bearer shares to stock exchange trading on the GPW Main Market List.

In its resolution, the Warsaw Stock Exchange Management Board stated that pursuant to § 19.1 and § 19.2 of the GPW Rules, 6,000,000 ordinary D-series bearer shares of the Company, having the nominal value of PLN 0.10 each, are admitted to stock exchange trading on the primary market.

At the same time, the GPW Management Board decided to introduce the above-mentioned shares of the Company to trading on the primary market as of September 22, 2021, subject to the registration of these shares and designating them with the their “PLCLNPH00015” code by the Central Securities Depository of Poland on September 22, 2021.